Tumor Lysis Syndrome is a complication of cancer treatment and occurs when a large number of cancer cells are killed quickly, which releases the cellular contents of the dying cells into the blood stream. This results in the rapid development of hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcemia. These abnormal blood levels can cause muscle weakness, kidney failure, cardiac arrhythmias, neurological changes and seizures.
Note: There are currently no drugs listed for "Tumor Lysis Syndrome".
